Global Oral Rehydration Salts (ORS) Market Research Report 2024

SKU ID : QYR-27187434 | Publishing Date : 12-Apr-2024 | No. of pages : 88

Oral rehydration salts (ORS) are a mixture of electrolytes (salts), and carbohydrates (in the form of sugar), which are dissolved in water. They are used to replace salts and water that the body loses when you have dehydration caused by gastroenteritis, diarrhoea, or vomiting.

The global Oral Rehydration Salts (ORS) market was valued at US$ 646.1 million in 2023 and is anticipated to reach US$ 826.2 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.

The classification of Oral Rehydration Salt includes Powder, Tablet and Solution. Tablets accounted for a share of 48% in the global Oral Rehydration Salt market.

Oral Rehydration Salt is widely used for Children Diarrhea, Adult Diarrhea and Other. In Oral Rehydration Salt market, the Adult Diarrhea holds an important share in terms of Application.

North America is the largest consumption place, with a consumption market share nearly 35%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 30%.

Market competition is intense. Abbott, Sanofi, Otsuka Pharmaceutical, AmJan, FDC and Prestige Brands, etc. are the leaders of the industry, with high-end customers. The top five manufacturers held 60% of the market, in terms of Oral Rehydration Salt revenue.

This report aims to provide a comprehensive presentation of the global market for Oral Rehydration Salts (ORS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Rehydration Salts (ORS).

Report Scope

The Oral Rehydration Salts (ORS) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Rehydration Salts (ORS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Rehydration Salts (ORS) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation


By Company


Abbott

Sanofi

Jianas Brothers

Trifecta Pharmaceuticals

Otsuka Pharmaceutical

Watson Pharma

FDC Limited

Multichem NZ Ltd

Shanghai Trifecta Pharma

Tianjin Teda Steyuan Pharm

ZouPing YiKang Group


Segment by Type


Solutions

Powders


Segment by Application


Infants

Children

Adults


Consumption by Region


North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Oral Rehydration Salts (ORS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Oral Rehydration Salts (ORS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
PRICE
2900
5800

4350


  • market Reports market Reports